FTC sues significant pharmacy reward managers above insulin price ranges The agency brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list cost of daily life-preserving insulin medicines. Elevance lowers steering on ‘unparalleled’ Medicaid challenges Executives said the increased c... https://remingtondimtq.alltdesign.com/not-known-factual-statements-about-healthcare-news-50329243